FAPI PET for Response Evaluation and Prognosis Prediction in Liver and Biliary Cancer Patients Treated With PD-1 Combination Therapy

NCT05662488 · clinicaltrials.gov ↗

UNKNOWN

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma
Bile Duct Cancer

Interventions

DIAGNOSTIC_TEST: [68Ga]FAPI PET/CT and [18F]FDG PET/CT

Sponsor

Peking Union Medical College Hospital